Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S7.58
P/E—
Fwd P/E25.41
PEG2.00
52W— – —
RSI—
Target$100.96 (+17.7%)
Beta0.85
Div—
Loading chart…
RSI (14)
Loading patterns…
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 45
Overbought · 100
Signal
Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
3Bullish
1Bearish
0Neutral
▲ Double Bottom — Two lows ~$77.35 — bullish reversal confirmed
▲ Double Bottom — Two lows ~$76.79 — bullish reversal confirmed
▲ Bull Flag — Breakout after +11% pole — bullish continuation
▼ Bear Flag — Breakdown after -10% pole — bearish continuation
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
88%
7/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$100.96
+17.7% upside
Low $84
—
High $110
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| Leerink Partners | Outperform | Market Perform → Outperform | ▲ Upgrade | 2026-07-25 |
| JP Morgan | Overweight | — | ↔ Maintain | 2026-07-24 |
| Piper Sandler | Overweight | — | ↔ Reiterate | 2026-07-24 |
| Truist Securities | Hold | — | ↔ Maintain | 2026-07-16 |
| Mizuho | Outperform | — | ↔ Maintain | 2026-07-15 |
| RBC Capital | Outperform | — | ↔ Maintain | 2026-07-13 |
| Citigroup | Buy | — | ↔ Maintain | 2026-07-08 |
| Evercore ISI Group | Outperform | — | ↔ Maintain | 2026-07-06 |
| BTIG | Buy | — | ↔ Maintain | 2026-06-30 |
| TD Cowen | Buy | — | ↔ Maintain | 2026-06-02 |
| Barclays | Overweight | — | ↔ Maintain | 2026-04-27 |
| Canaccord Genuity | Hold | — | ↔ Maintain | 2026-04-24 |
| Baird | Neutral | — | ↔ Maintain | 2026-04-24 |
| Goldman Sachs | Buy | — | ↔ Maintain | 2026-02-11 |
| Wells Fargo | Overweight | — | ↔ Maintain | 2026-02-11 |
| Stifel | Buy | — | ↔ Maintain | 2026-01-20 |
| UBS | Neutral | — | ↔ Maintain | 2026-01-12 |
Leerink Partners
2026-07-25
Outperform
(from Market Perform)
▲ Upgrade
JP Morgan
2026-07-24
Overweight
↔ Maintain
Piper Sandler
2026-07-24
Overweight
↔ Reiterate
Truist Securities
2026-07-16
Hold
↔ Maintain
Mizuho
2026-07-15
Outperform
↔ Maintain
RBC Capital
2026-07-13
Outperform
↔ Maintain
Citigroup
2026-07-08
Buy
↔ Maintain
Evercore ISI Group
2026-07-06
Outperform
↔ Maintain
BTIG
2026-06-30
Buy
↔ Maintain
TD Cowen
2026-06-02
Buy
↔ Maintain
Barclays
2026-04-27
Overweight
↔ Maintain
Canaccord Genuity
2026-04-24
Hold
↔ Maintain
Baird
2026-04-24
Neutral
↔ Maintain
Goldman Sachs
2026-02-11
Buy
↔ Maintain
Wells Fargo
2026-02-11
Overweight
↔ Maintain
Stifel
2026-01-20
Buy
↔ Maintain
UBS
2026-01-12
Neutral
↔ Maintain
Profitability
Gross Margin
77.84%TTM
Op. Margin
29.84%TTM
ROE
N/ATTM
Rev. Growth
13.60%YoY
Free Cash Flow
N/ATTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
6.81MRQ
Current Ratio
N/AMRQ
Cash
3.67BMRQ
Total Debt
702.90MMRQ
Net Debt
—MRQ
How EW Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 49.38B |
| Enterprise Value | 46.41B |
| Trailing P/E | 51.05 |
| Forward P/E | 25.41 |
| PEG Ratio (5yr) | 2.00 |
| Price/Sales (ttm) | 7.58 |
| Price/Book (mrq) | 4.79 |
| EV/Revenue | 7.13 |
| EV/EBITDA | 23.26 |
Share Statistics
| Avg Vol (3m) | 5.11M |
| Shares Outstanding | 575.80M |
| Float | 573.98M |
| % Held by Insiders | 0.18% |
| % Held by Institutions | 94.32% |
| Short Ratio | 2.32 |
| Short % of Float | 2.24% |
Profitability
| Gross Margin | 77.84% |
| Operating Margin (ttm) | 29.84% |
| Profit Margin | 15.43% |
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 6.51B |
| Revenue Growth (yoy) | 13.60% |
| Gross Profit (ttm) | 5.07B |
| EBITDA | 2.00B |
| Net Income (ttm) | 979.90M |
| Diluted EPS (ttm) | 1.68 |
| EPS Growth (yoy) | -25.40% |
Balance Sheet
| Total Cash (mrq) | 3.67B |
| Total Debt (mrq) | 702.90M |
| Debt / Equity (mrq) | 6.81 |
| Current Ratio (mrq) | N/A |
| Book Value / Share | 17.90 |
| Operating CF (ttm) | N/A |
| Free Cash Flow (ttm) | N/A |
Trading & Dividends
| Beta (5Y) | 0.85 |
| 50-Day MA | 87.33 |
| 200-Day MA | 83.50 |
| Fwd Dividend Yield | N/A |
| Payout Ratio | 0.00% |
Ownership Breakdown
Institutional 94.32%
Insider 0.18%
Public 5.5%
Short Interest
2.24% of float
Low
Institutional 13F Holdings
Famous investors who disclosed a position in EW in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-27 | ZOVIGHIAN BERNARD J | Chief Executive Officer | Sale at price 83.93 per share. | 2,920 | $245,134 |
| 2026-07-27 | ZOVIGHIAN BERNARD J | Chief Executive Officer | Stock Gift at price 0.00 per share. | 319 | — |
| 2026-07-10 | LIPPIS DANIEL J | Officer | Sale at price 91.70 per share. | 619 | $56,762 |
| 2026-07-10 | LIPPIS DANIEL J | Officer | Conversion of Exercise of derivative security at price 72.68 per share. | 619 | $44,989 |
| 2026-07-09 | MISTRAS THEODORA | Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 99,920 | — |
| 2026-06-30 | LIPPIS DANIEL J | Officer | Sale at price 91.40 per share. | 619 | $56,577 |
| 2026-06-30 | LIPPIS DANIEL J | Officer | Conversion of Exercise of derivative security at price 72.68 per share. | 619 | $44,989 |
| 2026-06-17 | ZOVIGHIAN BERNARD J | Chief Executive Officer | Sale at price 87.92 per share. | 523 | $45,982 |
| 2026-05-29 | DAHL ANDREW M | Officer | Sale at price 86.08 per share. | 567 | $48,853 |
| 2026-05-27 | BOBO DONALD E JR | Officer | Sale at price 86.42 per share. | 23,145 | $2,000,193 |
| 2026-05-22 | CHOPRA DAVEEN | Officer | Sale at price 84.60 per share. | 1,500 | $126,905 |
| 2026-05-18 | LIPPIS DANIEL J | Officer | Sale at price 81.14 per share. | 620 | $50,307 |
| 2026-05-18 | LIPPIS DANIEL J | Officer | Conversion of Exercise of derivative security at price 72.68 per share. | 620 | $45,062 |
| 2026-05-15 | BOBO DONALD E JR | Officer | Sale at price 81.82 - 82.07 per share. | 17,968 | $1,472,678 |
| 2026-05-12 | ZOVIGHIAN BERNARD J | Chief Executive Officer | Sale at price 77.92 - 78.40 per share. | 36,351 | $2,833,013 |
| 2026-05-12 | ZOVIGHIAN BERNARD J | Chief Executive Officer | Stock Gift at price 0.00 per share. | 26,640 | — |
| 2026-05-11 | MARKOWITZ WAYNE | Officer | Sale at price 79.73 per share. | 593 | $47,280 |
| 2026-05-11 | BOBO DONALD E JR | Officer | 13,457 | — | |
| 2026-05-11 | CHOPRA DAVEEN | Officer | 13,583 | — | |
| 2026-05-11 | ZOVIGHIAN BERNARD J | Chief Executive Officer | 47,207 | — | |
| 2026-05-11 | ULLEM SCOTT B | Chief Financial Officer | 19,830 | — | |
| 2026-05-11 | ZOVIGHIAN BERNARD J | Chief Executive Officer | Stock Gift at price 0.00 per share. | 9,711 | — |
| 2026-05-08 | LAVIOLETTE PAUL A | Director | Stock Award(Grant) at price 0.00 per share. | 3,251 | — |
| 2026-05-08 | SEQUEIRA RAMONA | Director | Stock Award(Grant) at price 0.00 per share. | 3,251 | — |
| 2026-05-08 | DAVIS LESLIE C. | Director | Stock Award(Grant) at price 0.00 per share. | 3,251 | — |
ZOVIGHIAN BERNARD J
Chief Executive Officer
Sale at price 83.93 per share.
2026-07-27
2,920 sh
$245,134
ZOVIGHIAN BERNARD J
Chief Executive Officer
Stock Gift at price 0.00 per share.
2026-07-27
319 sh
—
LIPPIS DANIEL J
Officer
Sale at price 91.70 per share.
2026-07-10
619 sh
$56,762
LIPPIS DANIEL J
Officer
Conversion of Exercise of derivative security at price 72.68 per share.
2026-07-10
619 sh
$44,989
MISTRAS THEODORA
Chief Financial Officer
Stock Award(Grant) at price 0.00 per share.
2026-07-09
99,920 sh
—
LIPPIS DANIEL J
Officer
Sale at price 91.40 per share.
2026-06-30
619 sh
$56,577
LIPPIS DANIEL J
Officer
Conversion of Exercise of derivative security at price 72.68 per share.
2026-06-30
619 sh
$44,989
ZOVIGHIAN BERNARD J
Chief Executive Officer
Sale at price 87.92 per share.
2026-06-17
523 sh
$45,982
DAHL ANDREW M
Officer
Sale at price 86.08 per share.
2026-05-29
567 sh
$48,853
BOBO DONALD E JR
Officer
Sale at price 86.42 per share.
2026-05-27
23,145 sh
$2,000,193
CHOPRA DAVEEN
Officer
Sale at price 84.60 per share.
2026-05-22
1,500 sh
$126,905
LIPPIS DANIEL J
Officer
Sale at price 81.14 per share.
2026-05-18
620 sh
$50,307
LIPPIS DANIEL J
Officer
Conversion of Exercise of derivative security at price 72.68 per share.
2026-05-18
620 sh
$45,062
BOBO DONALD E JR
Officer
Sale at price 81.82 - 82.07 per share.
2026-05-15
17,968 sh
$1,472,678
ZOVIGHIAN BERNARD J
Chief Executive Officer
Sale at price 77.92 - 78.40 per share.
2026-05-12
36,351 sh
$2,833,013
ZOVIGHIAN BERNARD J
Chief Executive Officer
Stock Gift at price 0.00 per share.
2026-05-12
26,640 sh
—
MARKOWITZ WAYNE
Officer
Sale at price 79.73 per share.
2026-05-11
593 sh
$47,280
BOBO DONALD E JR
Officer
2026-05-11
13,457 sh
—
CHOPRA DAVEEN
Officer
2026-05-11
13,583 sh
—
ZOVIGHIAN BERNARD J
Chief Executive Officer
2026-05-11
47,207 sh
—
ULLEM SCOTT B
Chief Financial Officer
2026-05-11
19,830 sh
—
ZOVIGHIAN BERNARD J
Chief Executive Officer
Stock Gift at price 0.00 per share.
2026-05-11
9,711 sh
—
LAVIOLETTE PAUL A
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-08
3,251 sh
—
SEQUEIRA RAMONA
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-08
3,251 sh
—
DAVIS LESLIE C.
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-08
3,251 sh
—